A citation-based method for searching scientific literature

Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, Bernard Haendler. Mol Oncol 2020
Times Cited: 12







List of co-cited articles
45 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Mark M Pomerantz, Fugen Li, David Y Takeda, Romina Lenci, Apurva Chonkar, Matthew Chabot, Paloma Cejas, Francisca Vazquez, Jennifer Cook, Ramesh A Shivdasani,[...]. Nat Genet 2015
219
33

Dysregulated Transcriptional Control in Prostate Cancer.
Simon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler. Int J Mol Sci 2019
14
25

Super-enhancers in the control of cell identity and disease.
Denes Hnisz, Brian J Abraham, Tong Ihn Lee, Ashley Lau, Violaine Saint-André, Alla A Sigova, Heather A Hoke, Richard A Young. Cell 2013
25

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Matthew R Smith, Fred Saad, Simon Chowdhury, Stéphane Oudard, Boris A Hadaschik, Julie N Graff, David Olmos, Paul N Mainwaring, Ji Youl Lee, Hiroji Uemura,[...]. N Engl J Med 2018
628
16

The Evolving Systemic Treatment Landscape for Patients with Advanced Prostate Cancer.
Martina Pagliuca, Carlo Buonerba, Karim Fizazi, Giuseppe Di Lorenzo. Drugs 2019
17
16

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens.
E David Crawford, Paul F Schellhammer, David G McLeod, Judd W Moul, Celestia S Higano, Neal Shore, Louis Denis, Peter Iversen, Mario A Eisenberger, Fernand Labrie. J Urol 2018
56
16

Absorption, distribution, metabolism and excretion of darolutamide (a novel non-steroidal androgen receptor antagonist) in rats.
Päivi Taavitsainen, Hille Gieschen, Timo Korjamo, Marja Kähkönen, Chira Malmström, Olaf Prien, Michael Niehues, Steffen Sandmann, Wiebke Janssen, Mikko Koskinen. Xenobiotica 2020
7
28

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Karim Fizazi, Neal Shore, Teuvo L Tammela, Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Iris Kuss,[...]. N Engl J Med 2019
386
16

Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
David C Wedge, Gunes Gundem, Thomas Mitchell, Dan J Woodcock, Inigo Martincorena, Mohammed Ghori, Jorge Zamora, Adam Butler, Hayley Whitaker, Zsofia Kote-Jarai,[...]. Nat Genet 2018
126
16

Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.
Theodoros Karantanos, Christopher P Evans, Bertrand Tombal, Timothy C Thompson, Rodolfo Montironi, William B Isaacs. Eur Urol 2015
183
16

Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies.
Anu-Maarit Moilanen, Reetta Riikonen, Riikka Oksala, Laura Ravanti, Eija Aho, Gerd Wohlfahrt, Pirjo S Nykänen, Olli P Törmäkangas, Jorma J Palvimo, Pekka J Kallio. Sci Rep 2015
190
16

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
Maha Hussain, Karim Fizazi, Fred Saad, Per Rathenborg, Neal Shore, Ubirajara Ferreira, Petro Ivashchenko, Eren Demirhan, Katharina Modelska, De Phung,[...]. N Engl J Med 2018
524
16


Super-enhancers in transcriptional regulation and genome organization.
Xi Wang, Murray J Cairns, Jian Yan. Nucleic Acids Res 2019
54
16

Super-Enhancer-Driven Transcriptional Dependencies in Cancer.
Satyaki Sengupta, Rani E George. Trends Cancer 2017
127
16

Recent Advances in Prostate Cancer Treatment and Drug Discovery.
Ekaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler. Int J Mol Sci 2018
115
16

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
16

Role of the DNA damage response in prostate cancer formation, progression and treatment.
Wenhao Zhang, Dik C van Gent, Luca Incrocci, Wytske M van Weerden, Julie Nonnekens. Prostate Cancer Prostatic Dis 2020
14
16

Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
Qunying Jia, Shuhua Chen, Yuan Tan, Yuejin Li, Faqing Tang. Exp Mol Med 2020
17
16

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.
Tatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, Kristin Reichert, Holger Steuber, Pascale Lejeune, Dominik Mumberg, Bernard Haendler. Int J Cancer 2019
32
16

SEdb: a comprehensive human super-enhancer database.
Yong Jiang, Fengcui Qian, Xuefeng Bai, Yuejuan Liu, Qiuyu Wang, Bo Ai, Xiaole Han, Shanshan Shi, Jian Zhang, Xuecang Li,[...]. Nucleic Acids Res 2019
85
16

ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer.
Ling Cai, Yi-Hsuan Tsai, Ping Wang, Jun Wang, Dongxu Li, Huitao Fan, Yilin Zhao, Rohan Bareja, Rui Lu, Elizabeth M Wilson,[...]. Mol Cell 2018
41
16

Master transcription factors and mediator establish super-enhancers at key cell identity genes.
Warren A Whyte, David A Orlando, Denes Hnisz, Brian J Abraham, Charles Y Lin, Michael H Kagey, Peter B Rahl, Tong Ihn Lee, Richard A Young. Cell 2013
16

Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells.
Qi Ma, Feng Yang, Carlos Mackintosh, Ranveer Singh Jayani, Soohwan Oh, Chunyu Jin, Sreejith Janardhanan Nair, Daria Merkurjev, Wubin Ma, Stephanie Allen,[...]. Cell Rep 2020
20
16

The mutational landscape of lethal castration-resistant prostate cancer.
Catherine S Grasso, Yi-Mi Wu, Dan R Robinson, Xuhong Cao, Saravana M Dhanasekaran, Amjad P Khan, Michael J Quist, Xiaojun Jing, Robert J Lonigro, J Chad Brenner,[...]. Nature 2012
16

Super-enhancers in cancer.
Palaniraja Thandapani. Pharmacol Ther 2019
39
16

A Phase Separation Model for Transcriptional Control.
Denes Hnisz, Krishna Shrinivas, Richard A Young, Arup K Chakraborty, Phillip A Sharp. Cell 2017
804
16

Long non-coding RNA MANCR is a target of BET bromodomain protein BRD4 and plays a critical role in cellular migration and invasion abilities of prostate cancer.
Masayuki Nagasawa, Kosuke Tomimatsu, Koji Terada, Kenta Kondo, Kazuko Miyazaki, Masaki Miyazaki, Daisuke Motooka, Daisuke Okuzaki, Tetsuya Yoshida, Susumu Kageyama,[...]. Biochem Biophys Res Commun 2020
11
18

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia.
Johannes Zuber, Junwei Shi, Eric Wang, Amy R Rappaport, Harald Herrmann, Edward A Sison, Daniel Magoon, Jun Qi, Katharina Blatt, Mark Wunderlich,[...]. Nature 2011
16

Coactivator condensation at super-enhancers links phase separation and gene control.
Benjamin R Sabari, Alessandra Dall'Agnese, Ann Boija, Isaac A Klein, Eliot L Coffey, Krishna Shrinivas, Brian J Abraham, Nancy M Hannett, Alicia V Zamudio, John C Manteiga,[...]. Science 2018
937
16

Selective inhibition of tumor oncogenes by disruption of super-enhancers.
Jakob Lovén, Heather A Hoke, Charles Y Lin, Ashley Lau, David A Orlando, Christopher R Vakoc, James E Bradner, Tong Ihn Lee, Richard A Young. Cell 2013
16


Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer.
Chengfei Liu, Wei Lou, Yezi Zhu, Joy C Yang, Nagalakshmi Nadiminty, Nilesh W Gaikwad, Christopher P Evans, Allen C Gao. Cancer Res 2015
156
16

The Metabolic Landscape of Prostate Cancer.
Francesca Giunchi, Michelangelo Fiorentino, Massimo Loda. Eur Urol Oncol 2019
41
16

Lipogenic effects of androgen signaling in normal and malignant prostate.
Chui Yan Mah, Zeyad D Nassar, Johannes V Swinnen, Lisa M Butler. Asian J Urol 2020
14
16

Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.
Vito Cucchiara, Joy C Yang, Vincenzo Mirone, Allen C Gao, Michael G Rosenfeld, Christopher P Evans. Cancers (Basel) 2017
22
16

Epigenetic modifications in prostate cancer.
Masahiro Sugiura, Hiroaki Sato, Manato Kanesaka, Yusuke Imamura, Shinichi Sakamoto, Tomohiko Ichikawa, Atsushi Kaneda. Int J Urol 2021
17
16

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
16

Fast gapped-read alignment with Bowtie 2.
Ben Langmead, Steven L Salzberg. Nat Methods 2012
16

Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.
Zhong Chen, Dayong Wu, Jennifer M Thomas-Ahner, Changxue Lu, Pei Zhao, Qingfu Zhang, Connor Geraghty, Pearlly S Yan, William Hankey, Benjamin Sunkel,[...]. Proc Natl Acad Sci U S A 2018
73
16

Isoform-specific Activities of Androgen Receptor and its Splice Variants in Prostate Cancer Cells.
Harika Nagandla, Matthew J Robertson, Vasanta Putluri, Nagireddy Putluri, Cristian Coarfa, Nancy L Weigel. Endocrinology 2021
6
33


Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer.
Yundong He, Ji Lu, Zhenqing Ye, Siyuan Hao, Liewei Wang, Manish Kohli, Donald J Tindall, Benyi Li, Runzhi Zhu, Liguo Wang,[...]. Nucleic Acids Res 2018
53
16

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.
Alastair Davies, Shaghayegh Nouruzi, Dwaipayan Ganguli, Takeshi Namekawa, Daksh Thaper, Simon Linder, Fatih Karaoğlanoğlu, Meltem E Omur, Soojin Kim, Maxim Kobelev,[...]. Nat Cell Biol 2021
20
16

Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Mark M Pomerantz, Xintao Qiu, Yanyun Zhu, David Y Takeda, Wenting Pan, Sylvan C Baca, Alexander Gusev, Keegan D Korthauer, Tesa M Severson, Gavin Ha,[...]. Nat Genet 2020
72
16

Abiraterone and increased survival in metastatic prostate cancer.
Johann S de Bono, Christopher J Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N Chi, Robert J Jones, Oscar B Goodman, Fred Saad,[...]. N Engl J Med 2011
8

Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD Study.
Susan Slovin, William Clark, Joan Carles, Andrew Krivoshik, Jung Wook Park, Fong Wang, Daniel George. JAMA Oncol 2018
27
8

Time to progression to castration-resistant prostate cancer after commencing combined androgen blockade for advanced hormone-sensitive prostate cancer.
Satoshi Tamada, Taro Iguchi, Minoru Kato, Jumpei Asakawa, Kazuaki Kita, Sayaka Yasuda, Takeshi Yamasaki, Yudai Matsuoka, Kazuyuki Yamaguchi, Kentaro Matsumura,[...]. Oncotarget 2018
19
8

ARN-509: a novel antiandrogen for prostate cancer treatment.
Nicola J Clegg, John Wongvipat, James D Joseph, Chris Tran, Samedy Ouk, Anna Dilhas, Yu Chen, Kate Grillot, Eric D Bischoff, Ling Cai,[...]. Cancer Res 2012
436
8

Systemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.
Rebecca M Joseph, Ann Louise Hunter, David W Ray, William G Dixon. Semin Arthritis Rheum 2016
75
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.